IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,502,113 | -11.7% | 549,915 | +36.7% | 0.00% | 0.0% |
Q2 2023 | $2,832,311 | +605.7% | 402,317 | +512.5% | 0.00% | – |
Q1 2023 | $401,330 | -38.4% | 65,684 | -35.6% | 0.00% | – |
Q4 2022 | $651,262 | +11.7% | 101,919 | +67.6% | 0.00% | – |
Q3 2022 | $583,000 | -59.4% | 60,818 | -53.3% | 0.00% | -100.0% |
Q2 2022 | $1,436,000 | -85.1% | 130,117 | -77.5% | 0.00% | -66.7% |
Q1 2022 | $9,622,000 | +40.2% | 577,920 | +60.7% | 0.00% | +50.0% |
Q4 2021 | $6,865,000 | -12.5% | 359,617 | +13.1% | 0.00% | -33.3% |
Q3 2021 | $7,843,000 | -46.9% | 318,034 | -43.9% | 0.00% | -50.0% |
Q2 2021 | $14,758,000 | +182.8% | 567,196 | +244.2% | 0.01% | +100.0% |
Q1 2021 | $5,218,000 | -62.3% | 164,787 | -44.8% | 0.00% | -57.1% |
Q4 2020 | $13,844,000 | +42.1% | 298,337 | +0.8% | 0.01% | +40.0% |
Q3 2020 | $9,742,000 | -40.6% | 295,908 | -50.4% | 0.01% | -58.3% |
Q2 2020 | $16,390,000 | +189.4% | 597,098 | +215.6% | 0.01% | +100.0% |
Q1 2020 | $5,664,000 | +599.3% | 189,213 | +546.8% | 0.01% | +500.0% |
Q4 2019 | $810,000 | +35.0% | 29,255 | -11.3% | 0.00% | 0.0% |
Q3 2019 | $600,000 | -42.7% | 32,982 | -22.8% | 0.00% | -50.0% |
Q2 2019 | $1,048,000 | +539.0% | 42,724 | +101.5% | 0.00% | +100.0% |
Q3 2017 | $164,000 | – | 21,204 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |